Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ Stent

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 500 participants.

Also called NCT01285999

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 500 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01285999
Other papers using this trial's data
  • PLATINUM China: a prospective, randomized investigation of the platinum chromium everolimus-eluting stent in de novo coronary artery lesions Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2015-03 DOI, PubMed 25631909

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01285999. Randomized; single masking; primary purpose treatment. Start 2011-01 (actual); primary completion 2013-03 (actual). Results posted on 2024-11-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prospective, Randomized, Multicenter Trial to Assess PROMUS™ Element™ Stent
Acronym
PTChina
Condition
Atherosclerosis
Intervention (Device)
PROMUS Element Coronary Stent System
Intervention (Device)
TAXUS Liberté Coronary Stent System
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct01285999
Content hash
24132413615689704d43798a3377a1a6d871430bafbcaa77155ea90bf8708038